Conatus Pharmaceuticals rises sharply

Shares of Conatus Pharmaceuticals (CNAT) look set to ride ICPT's coattails to another banner session.

The shares rallied 57% Thursday on optimism for liver disease treatment plays, fueled by ICPT's success in NASH.

CNAT +29% premarket.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs